FDA recommends changes to nicotine medications labeling
Commending FDA recommendation, GlaxoSmithKline (GSK) Consumer Healthcare said the action would be a positive step to help smokers to quit smoking and it will work with the FDA
Bristol Myers Squibb (BMS) is set to merge its separate research and development (R&D) departments into a single entity, effective from 1 January 2027.